NEUROD1 and Impaired glucose tolerance: These abnormalities may induce programming retardation in islet β-cell development in the early life of F2 offspring, ultimately leading to an increased body weight with impaired glucose tolerance, a reduced expression of Pdx1 and p-NeuroD1, and a decreased islet β-cell proliferation in the F2 offspring.